triazoles has been researched along with bromocriptine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N | 1 |
| Cauli, O; Fenu, S; Morelli, M | 1 |
| Freed, DJ; Gillam, MP; Middler, S; Molitch, ME | 1 |
3 other study(ies) available for triazoles and bromocriptine
| Article | Year |
|---|---|
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination | 1998 |
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors.
Topics: Animals; Bromocriptine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Motor Activity; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Stereotyped Behavior; Stimulation, Chemical; Triazoles | 2000 |
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Male; Nitriles; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome; Triazoles | 2002 |